Market Masters

GM is printing serious cash from its core truck and SUV business while the market stays skeptical about its EV transition costs. Cruise losses are shrinking and the ICE franchise still throws off enough free cash flow to fund buybacks and a growing capital return story. We hold it as a cheap, cyclically leveraged name where multiple expansion kicks in once the EV noise fades.

Lennar is the second largest homebuilder in the US, operating in a market where chronic housing undersupply and a locked-in existing homeowner base keep demand structurally elevated. The company's volume-first, margin-second strategy plus a capital-light land model positions it to take share as smaller builders struggle with financing costs. We hold it as a direct lever on the housing cycle with a balance sheet sturdy enough to survive any near-term rate pressure.

Toll Brothers dominates the luxury end of the US housing market, a segment where buyers are less rate-sensitive and supply constraints are structurally persistent. The company is sitting on a well-managed backlog and has been expanding margins through a shift toward higher-ASP communities in land-constrained sunbelt and coastal markets. We hold it as a cyclical lever on housing demand with a quality tilt, giving the portfolio exposure to a real-asset recovery without the vol of a spec builder.

Pultegroup is one of the largest US homebuilders, with a differentiated strategy targeting move-up and active adult buyers who are less rate-sensitive than first-time buyers. Tight existing home inventory keeps new construction demand elevated, and Pulte's spec-build model lets it turn land and lumber into closed sales faster than peers. We hold it as a cyclical lever that captures housing cycle upside while its balance sheet discipline limits the downside when rates bite.

D.R. Horton is the largest homebuilder in the US by volume, with a cost structure and land pipeline that lets it undercut competitors and keep move-in-ready inventory moving even when rates are elevated. The entry-level and first-move-up segments it dominates are structurally undersupplied, and its financial services arm adds a recurring margin layer on top of every closed sale. We hold it as a cyclical lever on housing demand with a balance sheet strong enough to survive a prolonged rate environment without blowing up.

Oshkosh builds specialty vehicles across defense, construction, and municipal markets, giving it durable exposure to multiple spending cycles at once. The defense segment is the near-term catalyst, with the USPS Next Generation Delivery Vehicle contract ramping production and adding a steady multi-year revenue stream. We hold it as a cyclical lever that captures government and infrastructure spending without putting all the risk on a single end market.

Arrow is one of two companies that effectively control global electronic component distribution, giving it durable pricing power and deep OEM relationships that are hard to disrupt. The industrial and aerospace mix in its component segment means demand holds up better than pure consumer electronics distributors when cycles turn. We hold it as a steady value play that should rerate as inventory destocking ends and component demand recovers.

Avnet is one of two dominant global electronics distributors, sitting between semiconductor makers and the manufacturers who need those chips, which means every capex upcycle flows through their order book. The company trades at a low single-digit forward multiple, pricing in a down-cycle that is already well underway and leaving room for a sharp re-rating as inventory destocking ends and industrial and defense demand recovers. We hold it as a cheap, cyclically leveraged way to capture the next electronics upcycle without taking single-chip-company risk.

Baxter is a medical products and renal care franchise trading well below historical multiples after years of operational drag, supply chain disruption, and a messy Hillrom integration. The divestiture of its kidney care segment as a standalone company cleans up the story and lets management focus on higher-margin hospital products and nutrition. We hold it as a recovery play where multiple expansion does most of the heavy lifting as execution improves.

SLB is the dominant oilfield services company globally, with unmatched scale across drilling, completions, and digital reservoir solutions that let it capture spend across the full upstream cycle. The real edge here is the technology and data platform layer: SLB's digital and AI tools are becoming stickier with operators, giving it pricing power that pure equipment players simply do not have. We hold it as a cyclical lever with a quality tilt, capturing upstream capex growth while benefiting from a secular shift toward higher-margin digital services.

ICON is one of the two dominant global contract research organizations, running clinical trials for pharma and biotech at scale across every major therapy area. The business compounds quietly: more drugs in development means more outsourced trials, and ICON's size gives it pricing power and the ability to absorb complex, high-value programs smaller CROs cannot. We hold it as a steady grower that anchors the healthcare sleeve without requiring a single binary event to work.

Lear is one of two dominant players in automotive seating and a growing force in electrical distribution systems, two components that every vehicle needs regardless of powertrain. The E-Systems segment is the real long-term story: as vehicles add more electrical content, Lear's wire harnesses and connection systems become more valuable per vehicle. We hold it as a cyclical lever with a rerating angle, picking up a structurally improving auto supplier at a depressed multiple while the market waits for volume recovery.

Avantor is a mission-critical supplier of ultra-pure materials and consumables to biopharma and advanced tech manufacturing, two end markets with sticky, repeat demand that supports durable margins. The business bottomed through a bioprocessing inventory correction cycle and is now working through a recovery in lab volumes and biopharma capex that should drive earnings reacceleration. We hold it as a leveraged play on the broader life science tools recovery without paying premium multiples for it.

NOV is a global oilfield equipment and services provider that benefits directly from upstream capital spending cycles, particularly as operators re-invest in drilling and completions infrastructure after years of underinvestment. The rig technology and completion tools segments give NOV exposure to both offshore recovery and North American activity without the commodity price volatility of an E&P name. We hold it as a cyclical lever to capture oilfield services upside while keeping direct energy risk off the table.

Meritage is one of the sharpest operators in US entry-level homebuilding, a segment that stays structurally undersupplied as millennials age into first purchases. The company runs lean specs, controls costs better than most peers, and converts orders to closings at a pace that shows up in returns on equity. We hold it as a cyclical lever on housing demand with a management team that has earned the right to trade at a premium to book.

Lennar is one of the two largest homebuilders in the US, with scale advantages in land acquisition, supply chain, and mortgage origination that smaller peers simply cannot match. Housing undersupply remains a structural tailwind, and Lennar's asset-light land strategy improves returns on capital as the cycle matures. We hold the Class B shares here for the same economic exposure at a lower per-share cost basis, giving us a capital-efficient way to own a dominant housing franchise.

Taylor Morrison is a mid-cap homebuilder with a deliberate focus on move-up and active adult buyers, segments that are less rate-sensitive than entry-level and carry stronger margins. The company has been steadily growing community count and expanding in high-demand Sun Belt markets where supply remains structurally short. We hold it as a cyclical lever on housing demand with better margin resilience than most peers its size.

DNOW is a distributor of pipes, valves, and fittings to the energy and industrial sectors, sitting at the intersection of oilfield activity and industrial capex cycles. The company has quietly built a leaner cost structure after years of restructuring, and a sustained upcycle in energy spending pulls revenue and margins higher with meaningful operating leverage. We hold it as a cyclical lever that adds direct energy infrastructure exposure to the portfolio without the commodity price risk of an E&P name.

CRH is the largest building materials company in North America, with aggregates, cement, and ready-mix operations that sit at the center of every infrastructure dollar spent. The US infrastructure bill and onshoring wave are pushing multi-year volume growth into a business that has serious pricing power and a proven acquisition playbook. We hold it as a steady compounder that anchors the portfolio with real-asset exposure and durable earnings through cycles.